GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: MOR-03087 | MOR-202 | MOR03087 | MOR202
Compound class:
Antibody
Comment: Felzartamab (MOR03087; MOR202) is a humanized anti-CD38 monoclonal antibody. It has immunosuppressive action and induces Fc-effector function. Anti-CD38 monoclonals are intended to target long-lived CD38+ autoantibody-secreting plasma cells and plasmablasts that persist in inflamed tissue and bone marrow niches, to mediate immunosuppression.
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11074 | felzartamab |
Synonyms ![]() |
| MOR-03087 | MOR-202 | MOR03087 | MOR202 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 1011 |
| Other databases | |
| GtoPdb PubChem SID | 500839865 |
| Search PubMed clinical trials | felzartamab |
| Search PubMed titles | felzartamab |
| Search PubMed titles/abstracts | felzartamab |